BRIMONIDINE TARTRATE AND TIMOLOL MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Brimonidine Tartrate And Timolol Maleate, and what generic alternatives are available?
Brimonidine Tartrate And Timolol Maleate is a drug marketed by Alembic, Apotex, Florida, Sandoz, Sentiss, and Upsher Smith Labs. and is included in six NDAs.
The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brimonidine Tartrate And Timolol Maleate
A generic version of BRIMONIDINE TARTRATE AND TIMOLOL MALEATE was approved as brimonidine tartrate; timolol maleate by SANDOZ on April 4th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
- What are the global sales for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
- What is Average Wholesale Price for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
Summary for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 6 |
Patent Applications: | 42 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE? | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE excipients list |
DailyMed Link: | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE at DailyMed |
![BRIMONIDINE TARTRATE AND TIMOLOL MALEATE drug patent expirations Drug patent expirations by year for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE](/p/graph/s/t/BRIMONIDINE_TARTRATE_AND_TIMOLOL_MALEATE-patent-expirations.png)
Recent Clinical Trials for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Allergan | Phase 3 |
Allergan | |
Allergan | Phase 4 |
See all BRIMONIDINE TARTRATE AND TIMOLOL MALEATE clinical trials
Pharmacology for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Drug Class | alpha-Adrenergic Agonist beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Antagonists |